Call us at 08068507599 to know more or simple avail a 1-on-1 consultation with our highly experienced in-house specialist, Dr
After 32 weeks of treatment, weight reductions were 5.1% in the semaglutide monotherapy group and 8.1% in the cagrilintide monotherapy group, whereas the combination group achieved a notable 15.6% weight reduction, highlighting a substantial difference in efficacy
Unlike semaglutide, whose retatrutide results comparison shows primarily weight and glycemic effects, retatrutide simultaneously improves hepatic fat, cardiovascular markers, and body composition in ways that reflect its triple-receptor mechanism
GLP-1 medications suppress appetite and slow gastric emptying, but they do not eliminate the need for good nutrition
But there is another element to this comeback